Founded in 2007, Nancyclotep develops and offers solutions ranging from R&D to clinical studies and production, enabling to meet the needs for the transfer of radiopharmaceuticals to the clinical setting.

Nancyclotep features state-of-the-art facilities including a radiochemistry and radiopharmacy laboratory, a preclinical studies platform, an industrial production laboratory, 3 PET-scans, an e-learning laboratory offering innovative solutions and a hospital environment enabling immediate access to both medical competencies and patients for clinically useful technological applications.

Nancyclotep is a public-private Economic Interest Group, located on the site of the University Hospital (CHRU) of Nancy (France) and employs 18 people.